Market revenue in 2023 | USD 7,229.9 million |
Market revenue in 2030 | USD 10,434.6 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | Cmos & cdmos |
Fastest growing segment | CMOs & CDMOS |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopharmaceutical Companies, CMOs & CDMOS, Academic And Research Organizations |
Key market players worldwide | Danone SA, Roche Holding AG ADR, Koninklijke DSM NV, Lonza Group Ltd, Novonesis AS ADR, Biocon, BioVectra, TerraVia - Assets, BiOZEEN |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbial fermentation technology market will help companies and investors design strategic landscapes.
Cmos & cdmos was the largest segment with a revenue share of 43.45% in 2023. Horizon Databook has segmented the Canada microbial fermentation technology market based on biopharmaceutical companies, cmos & cdmos, academic and research organizations covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of authorities such as the Public Health Agency of Canada (PHAC), which is involved in providing information on industrial fermentation, is driving awareness and boosting technology adoption in the local market. Organizations such as BIOTECanada, which is engaged in organizing workshops on Canada’s biotechnology landscape and advancing the region’s development with over 200 members, are driving the growth of the bioprocessing market.
Furthermore, government initiatives and investments in the development of a biopharmaceutical ecosystem are expected to boost microbial fermentation market growth in the country. For example, in 2019, the Canadian government granted around USD 39 million to establish state-of-the-art research labs across Canada. Furthermore, effective involvement of regulatory agencies in developing advanced medicinal therapy products in the country is expected to boost market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada microbial fermentation technology market , including forecasts for subscribers. This country databook contains high-level insights into Canada microbial fermentation technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account